Simplifying Global Compliance
St. Jude Results Reflect Troubled 2012, But Atrial Fib Sales Shine
Devices & Diagnostics Letter
St. Jude Medical expects less than half of its 2013 income to come from cardiac rhythm management (CRM) sales, due to an ongoing global slowdown in the market for cardiac devices, CEO Dan Starks said in a Tuesday earnings call.
To View This Article:
Subscribe To Devices & Diagnostics Letter
Buy This Article Now
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing